These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1090217)

  • 21. [Pharmacokinetics of anti-arrhythmics. 1. Fundamental principles].
    Lévy RH
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1223-8. PubMed ID: 6778415
    [No Abstract]   [Full Text] [Related]  

  • 22. Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat.
    Musa MN; Lower GM; Welling PG; Johnson BM; Kaiman BD; Bryan GT
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):497-512. PubMed ID: 4824824
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings].
    Ashford JJ; Carmichael D; Kidner PH
    Br J Pharmacol; 1979 Jul; 66(3):442P-443P. PubMed ID: 526732
    [No Abstract]   [Full Text] [Related]  

  • 25. An overdose fatality in a child involving disopyramide and sulindac.
    Singer P; Mozayani A
    J Anal Toxicol; 1995 Oct; 19(6):529-30. PubMed ID: 8926751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications].
    Lévy RH; Lévy S; Bricaud H
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1229-35. PubMed ID: 6778416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics and metabolism of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the rat].
    Klemm W; Morgenroth U; Joram U; Rodionov AP
    Pharmazie; 1985 Dec; 40(12):864-7. PubMed ID: 3841605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disopyramide in renal impairment.
    Whiting B; Elliott HL
    Lancet; 1977 Dec 24-31; 2(8052-8053):1363. PubMed ID: 74774
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the metabolism in man of oxisuran, a differential immunosuppressive drug.
    Crew MC; Vesell ES; Passananti GT; Gala RL; Di Carlo FJ
    Clin Pharmacol Ther; 1973; 14(6):1013-21. PubMed ID: 4584148
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics of 14C-dimethothiazine. I. Distribution and excretion following oral administration in the dog and rat.
    Lewellen OR; Templeton R
    Adv Biochem Psychopharmacol; 1974; 9(0):213-27. PubMed ID: 4151920
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical pharmacology of propafenone].
    Ambrosioni E; Marchesini B
    G Ital Cardiol; 1984 Apr; 14(4):285-92. PubMed ID: 6735021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and metabolism of fominoben (Noleptan) in man.
    Zimmer A
    Arzneimittelforschung; 1973 Dec; 23(12):1798-1801. PubMed ID: 4150215
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of disopyramide in patients with chronic renal failure.
    Francois B; Mallein R; Rondelet J; Lussignol M
    Eur J Drug Metab Pharmacokinet; 1983; 8(1):85-92. PubMed ID: 6861798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of renal failure on disopyramide pharmacokinetics [proceedings].
    Henry JA; Johnston A; Warrington SJ; Hamer NA
    Br J Clin Pharmacol; 1979 Apr; 7(4):427P-428P. PubMed ID: 444377
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluorescence photometric determination of disopyramide and mono-N-dealkylated disopyramide in plasma after separation by thin-layer chromatography.
    Gupta RN; Eng F; Lewis D; Kumana C
    Anal Chem; 1979 Mar; 51(3):455-8. PubMed ID: 532975
    [No Abstract]   [Full Text] [Related]  

  • 36. Disopyramide: clinical indications, pharmacokinetics and laboratory assessment.
    Taylor EH; Pappas AA
    Ann Clin Lab Sci; 1986; 16(4):289-95. PubMed ID: 2427003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disopyramide kinetics in patients with acute myocardial infarction.
    Ilett KF; Madsen BW; Woods JD
    Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of propisomide, a new antiarrhythmic agent, in biological samples by gas chromatography with a thermionic detector.
    Necciari J; Mery D; Sales Y; Berthet D; Cautreels W
    J Chromatogr; 1985 May; 341(1):202-7. PubMed ID: 4019687
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacokinetic characteristics and biodegradation of aprindin in man].
    Dodion L; de Suray JM; Deblecker M; Georges A
    Therapie; 1974; 29(2):221-32. PubMed ID: 4849380
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism of hexamethylmelamine-ring-14C in rats and man.
    Worzalla JF; Kaiman BD; Johnson BM; Ramirez G; Bryan GT
    Cancer Res; 1974 Oct; 34(10):2669-74. PubMed ID: 4414651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.